The FDA first stopped the company from marketing its products in 2022, but they have stayed on shelves pending an appeal.
The FDA first stopped the company from marketing its products in 2022, but they have stayed on shelves pending an appeal.
The FDA first stopped the company from marketing its products in 2022, but they have stayed on shelves pending an appeal.
The FDA first stopped the company from marketing its products in 2022, but they have stayed on shelves pending an appeal.
